Yaosheng Electronics, an international leader in transformer and inductor wire production, launched its new safety syringe on May 17 at the Howard Hotel. The event was attended by notable guests, including Presidential Adviser Shen Rongjin, National Policy Adviser He Meiyue, NTU Hematology-Oncology Professor Lin Kaixin, NTU Graduate Institute of Healthcare Organization Management Professor Su Xi, Shin Kong Hospital Thoracic Physician Xu Peisong, and Formosa Plastics Chairman Hong Fuyuan.
In his speech, Yaosheng Chairman Su Hao Xi, with over 30 years in the electronics industry, admitted that venturing into medical devices was unexpected. He explained that after the pandemic, he encountered the Stefano team, who informed him of the urgent need for medical supplies in Taiwan, motivating him to build a local supply chain. Su emphasized that moving into a new field required significant effort and posed considerable risk. The support from the Stefano team was crucial, from patent applications to environmental assessments, overcoming numerous challenges along the way.
Su thanked those who supported the project, especially former Vice Premier and current Presidential Adviser Shen Rongjin. After learning of Yaosheng’s plan to use Formosa Plastics’ materials, Shen contacted Chairman Hong Fuyuan, resolving a key material supply issue.
Su noted that their goal is a fully integrated, Made in Taiwan (MIT) process, but acknowledged the challenges, particularly when compared to Chinese manufacturers who can price a safety syringe at just one yuan. Yaosheng’s costs are much higher, and sterilization capabilities in Taiwan are limited. However, Su remained committed to the MIT approach, announcing that the upcoming Guanyin factory will house the world’s largest sterilization facility, capable of producing five billion safety syringes annually.
In his speech, Shen praised Yaosheng for aligning with national needs by investing heavily in developing safety syringes and needles. He highlighted Yaosheng’s adoption of Japan’s latest needle grinding technology and the establishment of a back-end sterilization facility, which completes the MIT production chain.
National Policy Adviser He Meiyue emphasized Taiwan’s world-class precision manufacturing, materials, and mold-making industries. She expressed confidence in Yaosheng’s ability to perfect this product, stating that Taiwan’s self-sufficiency in medical devices would enable rapid responses to future pandemics. She thanked Yaosheng on behalf of frontline healthcare workers for providing a product that enhances safety and convenience and hoped that, once well-established, Yaosheng could introduce the product internationally to benefit underprivileged countries.
NTU Hematology-Oncology Professor Lin Kaixin, specializing in pediatric medicine, praised the three-bevel grinding technology used in Yaosheng’s syringe, which reduces injection pain. Lin hopes for a rapid introduction of the product, recognizing the benefits of MIT manufacturing. Based on his gene therapy experience, he believes Taiwan’s medical technology far exceeds that of mainland China, and Yaosheng’s uncompromising approach is commendable.
Syringes are an essential medium for administering vaccines, medications, and nutrients into the human body and are frequently used in medical settings. Based on her experience as a frontline healthcare worker, Su Xi noted that needlestick injuries among her colleagues happen regularly, leading to high infection risks. This has caused many to resign, exacerbating the shortage of medical staff and limiting available hospital beds. Consequently, critical patients often cannot receive timely care.
Su Xi, with firsthand experience as a healthcare worker, shared that needlestick injuries among her colleagues are common, leading to infection risks, resignations, and staffing shortages that limit patient care. She praised Yaosheng’s new syringe, highlighting its safety and functionality. The syringe eliminates medication leakage and residue, facilitates IV medication, and reduces medical waste disposal costs. The Japan and Korea-certified three-bevel needle head prevents microvascular rupture, minimizing pain—a blessing for patients needing frequent injections.
Having passed Taiwan’s rigorous inspections and with patent applications underway worldwide, this high-specification safety syringe marks Yaosheng’s entry into the high-end medical device sector. Looking ahead, Yaosheng plans to expand into smart energy and carbon reduction technologies, driving innovation and addressing environmental challenges, rooted firmly in Taiwan.
